.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Cerilliant
Federal Trade Commission
Express Scripts
Boehringer Ingelheim
Fuji
McKinsey
Queensland Health
Baxter
US Army

Generated: December 17, 2017

DrugPatentWatch Database Preview

ZERIT XR Drug Profile

« Back to Dashboard

Which patents cover Zerit Xr, and what generic alternatives are available?

Zerit Xr is a drug marketed by Bristol Myers Squibb and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in ZERIT XR is stavudine. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the stavudine profile page.
Drug patent expirations by year for ZERIT XR

Medical Subject Heading (MeSH) Categories for ZERIT XR

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-001Dec 31, 2002DISCNNoNo► Subscribe► SubscribeY► Subscribe
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-004Dec 31, 2002DISCNNoNo► Subscribe► SubscribeY► Subscribe
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-002Dec 31, 2002DISCNNoNo► Subscribe► SubscribeY► Subscribe
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-003Dec 31, 2002DISCNNoNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ZERIT XR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-001Dec 31, 2002► Subscribe► Subscribe
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-004Dec 31, 2002► Subscribe► Subscribe
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-003Dec 31, 2002► Subscribe► Subscribe
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-002Dec 31, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Merck
Argus Health
McKinsey
Medtronic
US Department of Justice
Accenture
Healthtrust
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot